Effect of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors on Trabecular Bone Score and Bone Mineral Density in Primary Fibromyalgia
Hamoud, H., Ghait, M., Hussein, Y., Harb, M. (2019). Effect of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors on Trabecular Bone Score and Bone Mineral Density in Primary Fibromyalgia. EKB Journal Management System, 74(3), 648-659. doi: 10.21608/ejhm.2019.23682
Hesham S. Hamoud; Mohamed M. Ghait; Yasser A. Hussein; Muhammad M. Harb. "Effect of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors on Trabecular Bone Score and Bone Mineral Density in Primary Fibromyalgia". EKB Journal Management System, 74, 3, 2019, 648-659. doi: 10.21608/ejhm.2019.23682
Hamoud, H., Ghait, M., Hussein, Y., Harb, M. (2019). 'Effect of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors on Trabecular Bone Score and Bone Mineral Density in Primary Fibromyalgia', EKB Journal Management System, 74(3), pp. 648-659. doi: 10.21608/ejhm.2019.23682
Hamoud, H., Ghait, M., Hussein, Y., Harb, M. Effect of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors on Trabecular Bone Score and Bone Mineral Density in Primary Fibromyalgia. EKB Journal Management System, 2019; 74(3): 648-659. doi: 10.21608/ejhm.2019.23682

Effect of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors on Trabecular Bone Score and Bone Mineral Density in Primary Fibromyalgia

The Egyptian Journal of Hospital Medicine
Article 24, Volume 74, Issue 3, January 2019, Page 648-659  XML PDF (1011.35 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2019.23682
View on SCiNiTO View on SCiNiTO
Authors
Hesham S. Hamoud; Mohamed M. Ghait; Yasser A. Hussein; Muhammad M. Harb email
Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
Abstract
Background: fibromyalgia is characterized by chronic widespread pain classified as primary and concomitant. Aim of the Work: this work aimed to determine the correlation between selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) usage and bone mineral density (BMD) and trabecular bone score (TBS) changes in primary fibromyalgia patients.
Patients and Methods: The present study was conducted on study on 100 Egyptian patients diagnosed as primary fibromyalgia categorized according to drug medication into two 2 groups, 50 patients on SSRIs and 50 patients on SNRIs, recruited from Rheumatology, Physical Medicine and Rehabilitation Departments at Al-Hussein and Sayed Galal, Al-Azhar University Hospitals. In addition to another 50 age matched the control group subdivided into 25 primary fibromyalgia patients not on those drugs and 25 healthy individuals selected by nurses and medical staff, after an informed consent from all subjects from June 2018 to December 2018.Results: DXA and TBS revealed that usage of SSRIs and SNRI was significantly associated with low BMD (Osteopenia and osteoporosis) specially spine BMD reduction with low TBS (partially degraded and degraded) particularly for old people. Conclusion: the present study provided evidence that usage of SSRIs or SNRI was significantly associated with low BMD (Osteopenia and osteoporosis) specially spine BMD reduction with low TBS (Partially degraded and degraded) particularly for old people and despite low BMD was found in the SRI users; it also found in 1ry fibromyalgia not on SRIs so 1ry fibromyalgia should also be considered as a contributing factor for low BMD. 
Keywords
ssri; SNRI; FMS; Fibromyalgia; Osteoporosis; TBS; BMD; Bone Mineral Density; Trabecular Bone Score
Statistics
Article View: 267
PDF Download: 423